• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down0.64% Nasdaq Down0.55%

    Oramed Pharmaceuticals Inc. (ORMP)

    -NasdaqCM
    6.66 Down 0.16(2.35%) May 29, 4:00PM EDT
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingNov 30, 2014Aug 31, 2014May 31, 2014Feb 28, 2014
    Total Revenue -   -   -   -  
    Cost of Revenue -   -   -   -  
    Gross Profit -   -   -   -  
    Operating Expenses
    Research Development1,302  764  1,089  674  
    Selling General and Administrative600  885  814  512  
    Non Recurring -   -   -   -  
    Others -   -   -   -  
    Total Operating Expenses -   -   -   -  
    Operating Income or Loss (1,902) (1,649) (1,903) (1,186)
    Income from Continuing Operations
    Total Other Income/Expenses Net27  25  79  74  
    Earnings Before Interest And Taxes(1,875)(1,624)(1,824)(1,112)
    Interest Expense21  1  4  3  
    Income Before Tax(1,896)(1,625)(1,828)(1,115)
    Income Tax Expense -  4   -   -  
    Minority Interest -   -   -   -  
    Net Income From Continuing Ops(1,896)(1,629)(1,828)(1,115)
    Non-recurring Events
    Discontinued Operations -   -   -   -  
    Extraordinary Items -   -   -   -  
    Effect Of Accounting Changes -   -   -   -  
    Other Items -   -   -   -  
    Net Income (1,896) (1,629) (1,828) (1,115)
    Preferred Stock And Other Adjustments -   -   -   -  
    Net Income Applicable To Common Shares (1,896) (1,629) (1,828) (1,115)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.